170 related articles for article (PubMed ID: 15073669)
1. Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial.
Sacks SL
J Infect Dis; 2004 Apr; 189(8):1341-7. PubMed ID: 15073669
[TBL] [Abstract][Full Text] [Related]
2. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
[TBL] [Abstract][Full Text] [Related]
3. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
Leone P; Warren T; Hamed K; Fife K; Wald A
Sex Transm Dis; 2007 Nov; 34(11):900-7. PubMed ID: 17538513
[TBL] [Abstract][Full Text] [Related]
4. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
[TBL] [Abstract][Full Text] [Related]
5. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.
Sacks SL; Aoki FY; Martel AY; Shafran SD; Lassonde M
Clin Infect Dis; 2005 Oct; 41(8):1097-104. PubMed ID: 16163627
[TBL] [Abstract][Full Text] [Related]
6. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
Diaz-Mitoma F; Sibbald RG; Shafran SD; Boon R; Saltzman RL
JAMA; 1998 Sep; 280(10):887-92. PubMed ID: 9739972
[TBL] [Abstract][Full Text] [Related]
7. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
Aoki FY; Tyring S; Diaz-Mitoma F; Gross G; Gao J; Hamed K
Clin Infect Dis; 2006 Jan; 42(1):8-13. PubMed ID: 16323085
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
[TBL] [Abstract][Full Text] [Related]
9. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.
Schacker T; Hu HL; Koelle DM; Zeh J; Saltzman R; Boon R; Shaughnessy M; Barnum G; Corey L
Ann Intern Med; 1998 Jan; 128(1):21-8. PubMed ID: 9424977
[TBL] [Abstract][Full Text] [Related]
10. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
[TBL] [Abstract][Full Text] [Related]
11. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
12. 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study.
Bodsworth N; Bloch M; McNulty A; Denham I; Doong N; Trottier S; Adena M; Bonney MA; Agnew J;
Sex Health; 2008 Sep; 5(3):219-25. PubMed ID: 18771636
[TBL] [Abstract][Full Text] [Related]
13. One-day famciclovir vs. placebo in patient-initiated episodic treatment of recurrent genital herpes in immunocompetent Black patients.
Leone P; Abudalu M; Mitha E; Gani M; Zhou W; Hamed K
Curr Med Res Opin; 2010 Mar; 26(3):653-61. PubMed ID: 20070143
[TBL] [Abstract][Full Text] [Related]
14. Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials.
Tyring SK; Diaz-Mitoma F; Shafran SD; Locke LA; Sacks SL; Young CL
J Cutan Med Surg; 2003; 7(6):449-54. PubMed ID: 15931690
[TBL] [Abstract][Full Text] [Related]
15. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
[TBL] [Abstract][Full Text] [Related]
16. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial.
Chosidow O; Drouault Y; Leconte-Veyriac F; Aymard M; Ortonne JP; Pouget F; Revuz J; Decazes JM; Malkin JE
Br J Dermatol; 2001 Apr; 144(4):818-24. PubMed ID: 11298543
[TBL] [Abstract][Full Text] [Related]
17. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.
Tyring S; Barbarash RA; Nahlik JE; Cunningham A; Marley J; Heng M; Jones T; Rea T; Boon R; Saltzman R
Ann Intern Med; 1995 Jul; 123(2):89-96. PubMed ID: 7778840
[TBL] [Abstract][Full Text] [Related]
18. Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trial.
Bartlett BL; Tyring SK; Fife K; Gnann JW; Hadala JT; Kianifard F; Berber E
J Clin Virol; 2008 Oct; 43(2):190-5. PubMed ID: 18621575
[TBL] [Abstract][Full Text] [Related]
19. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Wagstaff AJ
Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
[TBL] [Abstract][Full Text] [Related]
20. Famciclovir for the treatment of recurrent genital herpes: a clinical and pharmacological perspective.
Vinh DC; Aoki FY
Expert Opin Pharmacother; 2006 Nov; 7(16):2271-86. PubMed ID: 17059383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
